56 year old women who was diabetic FbS : 90-120, PPBS: 140-180 for aro

56 year old women who was diabetic FbS : 90-120, PPBS: 140-180 for around 6 years suddenly after doing intermittent fasting (mainly cutting carb) has a normal FBS & PPBS. HbA1C - 6.9

Reading File

Finding Sources

Reading File

This is a clinically interesting case. Here's a thorough analysis:

Clinical Interpretation

What's Happening

This 56-year-old woman with Type 2 Diabetes (T2DM) for 6 years has achieved what is classically termed Partial Diabetes Remission (some would argue near-complete remission) through intermittent fasting + carbohydrate restriction.

Parameter	Before	After IF
FBS	90–120 mg/dL	Normal (<100)
PPBS	140–180 mg/dL	Normal (<140)
HbA1c	(implied ~7–8%)	6.9%

Is This True Remission?

By current consensus criteria (ADA/Lancet 2021), T2DM remission is defined as:

HbA1c < 6.5% sustained for at least 3 months off all antidiabetic medication

Her HbA1c of 6.9% sits just above that threshold, placing her in a prediabetic/near-remission zone rather than full remission. However, normalized FBS and PPBS are highly significant and functionally meaningful.

This is best described as a marked glycemic improvement or partial remission — still a tremendous clinical win.

Why Did Intermittent Fasting + Low-Carb Work?

Several synergistic mechanisms explain this:

1. Reduced Hepatic Glucose Output Carbohydrate restriction directly lowers postprandial glucose spikes and reduces the substrate load for hepatic gluconeogenesis. Fasting depletes liver glycogen, further reducing fasting glucose.

2. Improved Insulin Sensitivity Weight loss (even modest, 5–10%) and reduced visceral/ectopic fat (especially intrahepatic fat) dramatically improve hepatic and peripheral insulin sensitivity. The DiRECT trial showed that T2DM remission correlated directly with amount of weight lost — 86% remission in those losing ≥15 kg.

3. Beta-Cell Recovery The "personal fat threshold" hypothesis (Roy Taylor's work) proposes that T2DM is caused by fat accumulation in the liver and pancreas exceeding a personal threshold. Dietary-induced fat loss from these organs can restore beta-cell function, especially in patients with shorter disease duration (<6 years is a favorable window — she's right at this boundary).

4. Caloric Deficit from IF Intermittent fasting creates a natural caloric deficit, reducing overall energy intake and promoting fat mobilization without requiring explicit calorie counting.

Clinical Significance of HbA1c 6.9%

Still above the remission cutoff of 6.5%
Reflects average glucose over ~3 months — if her diet change is recent, the HbA1c will continue to fall
Trend matters: if she maintains her lifestyle, the next HbA1c (in 3 months) may cross into the 6.0–6.4% range
At 6.9%, she remains at risk for microvascular complications if sustained, but risk is substantially lower than at 7.5–8%

What to Monitor & Advise

Recheck in 3 months:

Repeat HbA1c — target < 6.5% off medications
FBS, PPBS
Lipid profile (low-carb diets can raise LDL in some patients)
Renal function (IF can mildly affect eGFR acutely)
Uric acid (fasting raises urate transiently)

Medications:

If she was on metformin or any antidiabetic, review whether to continue or taper under physician guidance
Hypoglycemia risk is low given her glucose levels, but monitor if on sulfonylureas

Sustaining the benefit:

The evidence strongly supports continued low-carbohydrate or Mediterranean-style eating to maintain glycemic control
Muscle-preserving exercise (resistance training) enhances insulin sensitivity independently
Aggressive carb reintroduction will likely cause relapse

Key Takeaway

This patient has achieved a near-remission of T2DM through metabolic intervention — a biologically sound outcome supported by the DiRECT trial and mechanistic data on ectopic fat mobilization and beta-cell recovery. Her disease duration of ~6 years is at the favorable end of the window for remission. The HbA1c of 6.9% should be followed closely; continued adherence gives a realistic chance of crossing into full remission (< 6.5%) within the next few months.

— Fuster & Hurst's The Heart, 15th Ed.; Goldman-Cecil Medicine, International Ed.

This is a shared conversation. Sign in to Orris to start your own chat.